CDC Expands RSV Vaccine Recommendations Amid Market Gains
TL;DR
Health Secretary Robert F. Kennedy Jr. approved an expansion of CDC's RSV vaccine recommendations to include adults aged 50-59 at high risk, after firing the original advisory committee members. This move benefits vaccine makers Moderna and Pfizer, whose shares rose following the announcement, and reflects ongoing vaccine regulation despite Kennedy's disruptions to the public health apparatus.
- Kennedy Expands CDC Recommendation for RSV Vaccines. Moderna, Pfizer Shares Are Up Barron's
- US CDC accepts ousted vaccine panel's recommendations for RSV, meningococcal shots Reuters
- RFK Jr. Just Did The Unexpected. He Helped Moderna. Investor's Business Daily
- In surprise move, RFK Jr.'s vaccine committee votes to recommend RSV shot for infants USA Today
- RSV vaccine access expanded to some people in their 50s, according to CDC website AP News
Want the full story? Read the original reporting
Read on Barron's